Click: personalized digital therapeutics for cognitive, neurobehavioral disorders

Click harnesses user experience data to develop apps for neurobehavioral disorders

Click is developing a pipeline of personalized prescription digital therapeutics that could be used alone or in combination with traditional therapeutics to treat cognitive and neurobehavioral disorders.

Launched in 2012, Click Therapeutics Inc. markets a smartphone app dubbed Clickotine to treat smoking cessation and has a pipeline of eight apps in indications “where behavioral and cognitive intervention could really move the needle on a clinically

Read the full 658 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE